Credit Agricole S A Has $2.28 Million Holdings in Steris PLC (STE)
Credit Agricole S A cut its holdings in Steris PLC (NYSE:STE) by 61.1% in the fourth quarter, Holdings Channel reports. The fund owned 26,078 shares of the medical equipment provider’s stock after selling 41,031 shares during the quarter. Credit Agricole S A’s holdings in Steris were worth $2,282,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Benjamin F. Edwards & Company Inc. lifted its stake in Steris by 5.9% in the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 9,817 shares of the medical equipment provider’s stock valued at $859,000 after acquiring an additional 547 shares during the last quarter. Comerica Bank raised its position in shares of Steris by 0.9% in the fourth quarter. Comerica Bank now owns 68,219 shares of the medical equipment provider’s stock valued at $6,255,000 after purchasing an additional 628 shares during the period. Crossmark Global Holdings Inc. raised its position in shares of Steris by 6.9% in the fourth quarter. Crossmark Global Holdings Inc. now owns 9,810 shares of the medical equipment provider’s stock valued at $858,000 after purchasing an additional 630 shares during the period. OppenheimerFunds Inc. raised its position in shares of Steris by 9.2% in the fourth quarter. OppenheimerFunds Inc. now owns 8,352 shares of the medical equipment provider’s stock valued at $731,000 after purchasing an additional 703 shares during the period. Finally, Swiss National Bank raised its position in shares of Steris by 0.6% in the third quarter. Swiss National Bank now owns 142,255 shares of the medical equipment provider’s stock valued at $12,575,000 after purchasing an additional 800 shares during the period. Hedge funds and other institutional investors own 89.43% of the company’s stock.
In related news, VP Karen L. Burton sold 1,500 shares of the business’s stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $85.59, for a total transaction of $128,385.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Jacqueline B. Kosecoff sold 2,744 shares of the business’s stock in a transaction on Wednesday, February 28th. The stock was sold at an average price of $91.94, for a total transaction of $252,283.36. The disclosure for this sale can be found here. Insiders have sold 9,462 shares of company stock worth $858,813 in the last ninety days. 2.55% of the stock is currently owned by insiders.
Steris PLC (NYSE:STE) opened at $89.76 on Friday. Steris PLC has a 52-week low of $67.55 and a 52-week high of $93.71. The company has a market cap of $7,610.00, a P/E ratio of 31.61 and a beta of 1.17. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.82 and a quick ratio of 2.22.
Steris (NYSE:STE) last announced its earnings results on Wednesday, February 7th. The medical equipment provider reported $1.12 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.07 by $0.05. Steris had a net margin of 9.42% and a return on equity of 11.57%. The business had revenue of $661.90 million for the quarter, compared to analyst estimates of $663.17 million. During the same quarter in the previous year, the firm posted $0.98 earnings per share. Steris’s revenue was up 2.3% compared to the same quarter last year. sell-side analysts forecast that Steris PLC will post 4.13 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 28th. Investors of record on Wednesday, February 28th will be given a dividend of $0.31 per share. The ex-dividend date is Tuesday, February 27th. This represents a $1.24 dividend on an annualized basis and a yield of 1.38%. This is a positive change from Steris’s previous quarterly dividend of $0.21. Steris’s payout ratio is 43.66%.
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.